Further to DrugAlert Volume 353, HPS Pharmacies wish to give notice that Pfizer Australia Pty Ltd is continuing to experience an interruption to the supply of Isuprel™ as follows:
The supply interruption is due to a manufacturing delay. Normal supplies are expected to resume in mid-September, 2017. While wholesaler stocks of Isuprel™ ampoules are exhausted, HPS Pharmacies are still able to source a limited supply for the benefit of our clients.
Alternative supplies of isoprenaline 200µg/1ml are available from Medsurge. This product is presented in packs of five ampoules.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.